Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
DENTSPLY SIRONA Inc is a medical instruments & supplies business based in the US. DENTSPLY SIRONA shares (XRAY) are listed on the NASDAQ and all prices are listed in US Dollars. DENTSPLY SIRONA employs 15,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$59.60|
|52-week range||$41.30 - $69.42|
|50-day moving average||$61.48|
|200-day moving average||$63.70|
|Wall St. target price||$73.17|
|Dividend yield||$0.41 (0.66%)|
|Earnings per share (TTM)||$1.68|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-2.66%|
|1 month (2021-08-24)||-1.60%|
|3 months (2021-06-24)||-6.54%|
|6 months (2021-03-24)||-1.24%|
|1 year (2020-09-24)||39.74%|
|2 years (2019-09-24)||12.37%|
|3 years (2018-09-24)||56.47%|
|5 years (2016-09-23)||0.40%|
Valuing DENTSPLY SIRONA stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DENTSPLY SIRONA's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DENTSPLY SIRONA's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, DENTSPLY SIRONA shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
DENTSPLY SIRONA's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 18.9096. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DENTSPLY SIRONA's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
DENTSPLY SIRONA's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $953 million.
The EBITDA is a measure of a DENTSPLY SIRONA's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.1 billion|
|Operating margin TTM||15.13%|
|Gross profit TTM||$1.7 billion|
|Return on assets TTM||4.28%|
|Return on equity TTM||7.59%|
|Market capitalisation||$13.6 billion|
TTM: trailing 12 months
There are currently 3.2 million DENTSPLY SIRONA shares held short by investors – that's known as DENTSPLY SIRONA's "short interest". This figure is 6.6% up from 3.0 million last month.
There are a few different ways that this level of interest in shorting DENTSPLY SIRONA shares can be evaluated.
DENTSPLY SIRONA's "short interest ratio" (SIR) is the quantity of DENTSPLY SIRONA shares currently shorted divided by the average quantity of DENTSPLY SIRONA shares traded daily (recently around 1.4 million). DENTSPLY SIRONA's SIR currently stands at 2.34. In other words for every 100,000 DENTSPLY SIRONA shares traded daily on the market, roughly 2340 shares are currently held short.
However DENTSPLY SIRONA's short interest can also be evaluated against the total number of DENTSPLY SIRONA shares, or, against the total number of tradable DENTSPLY SIRONA shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DENTSPLY SIRONA's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 DENTSPLY SIRONA shares in existence, roughly 10 shares are currently held short) or 0.0149% of the tradable shares (for every 100,000 tradable DENTSPLY SIRONA shares, roughly 15 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against DENTSPLY SIRONA.
Find out more about how you can short DENTSPLY SIRONA stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like DENTSPLY SIRONA.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and DENTSPLY SIRONA's overall score of 23 (as at 12/31/2018) is pretty good – landing it in it in the 26th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like DENTSPLY SIRONA is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 5.65/100
DENTSPLY SIRONA's environmental score of 5.65 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that DENTSPLY SIRONA is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 12.07/100
DENTSPLY SIRONA's social score of 12.07 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that DENTSPLY SIRONA is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 7.29/100
DENTSPLY SIRONA's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that DENTSPLY SIRONA is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. DENTSPLY SIRONA scored a 1 out of 5 for controversy – the highest score possible, reflecting that DENTSPLY SIRONA has managed to keep its nose clean.
|Total ESG score||23|
|Total ESG percentile||26.38|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||1|
Dividend payout ratio: 14.14% of net profits
Recently DENTSPLY SIRONA has paid out, on average, around 14.14% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.71% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), DENTSPLY SIRONA shareholders could enjoy a 0.71% return on their shares, in the form of dividend payments. In DENTSPLY SIRONA's case, that would currently equate to about $0.41 per share.
While DENTSPLY SIRONA's payout ratio might seem low, this can signify that DENTSPLY SIRONA is investing more in its future growth.
DENTSPLY SIRONA's most recent dividend payout was on 7 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 September 2021 (the "ex-dividend date").
DENTSPLY SIRONA's shares were split on a 2:1 basis on 17 July 2006. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your DENTSPLY SIRONA shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for DENTSPLY SIRONA shares which in turn could have impacted DENTSPLY SIRONA's share price.
Over the last 12 months, DENTSPLY SIRONA's shares have ranged in value from as little as $41.3002 up to $69.4206. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DENTSPLY SIRONA's is 0.9154. This would suggest that DENTSPLY SIRONA's shares are less volatile than average (for this exchange).
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.